Innovative AI-Based Doppler for Point of Care Diagnosis

Keeping Patients Out
of the Emergency Department

Technology
Innovation

We develop innovative AI- based lung Doppler  diagnostic devices. Our  technology is being developed for bedside diagnosis and monitoring of cardio-pulmonary diseases in emergency and primary care environments.

Value to 
Healthcare Services

Our technology can provide accurate and rapid diagnostics to improve patient care. EchoLogic-Medical technology will potentially: 

  • Reveals un-diagnosed cardio-pulmonary disease
  • Increases diagnostic confidence.
  • Improves disease management

Designed to Support the Entire Patient Treatment Cycle

Feature
Highlights

EchoLogic-Medical leads the way towards the development of a fast, simple and reliable method for diagnosis of heart and lung diseases.

Simple Operation

Does not require use by skilled physicians or specialized technicians in contrast to conventional echo-based devices.

Fast Patient Diagnosis

Our AI based devices produces results in 3-5 minutes.

Accurate Results

The results of extensive clinical studies show an accuracy of nearly 90%.

Established in 2006, EchoLogic-Medical Ltd. develops innovative ultrasound Doppler systems for the diagnosis and monitoring of cardiac and pulmonary diseases. The company will deliver a fast, reliable and non-invasive method of diagnosis. Our technology has undergone successful clinical trials in the United States, Europe and Israel. The company research and development center is based in Haifa, Israel.

Contact Us

For further information about EchoLogic-Medical technology, contact us at:

Office: +972 4-8500101
Email: info@echologic-medical.com

Caution:  Echologic Medical is developing an investigational device. Limited by Federal law for investigational use only in the United States

Copyright EchoLogic Medical Ltd. 2019. All rights reserved.